Home / TAK : NYSE

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does TAK make money? Does TAK have pricing power? What's the Earnings Whisper? Will TAK profit more as the business scales? What is TAK's management track record? Is TAK's current price justified?

Takeda Pharmaceutical Company Limited

$20.91 +$5.29 (+33.87%)

NYSE · 30 Oct 2026 20:00 UTC

Previous Close

$20.01

Day Range

$20.79$21.22

Year Range

$13.35$21.22

Market Cap

66.81B

AVG Volume

3.01M

Trailing/Forward PE

27.16/0.2

PEG ratio

3.39

Dividend Yield

3.04%

Next Earnings Date

2027-01-28

Primary Exchange

New York Stock Exchange

Revenue (JPY) · Q

TAK Revenue (JPY) by quarter
Period	Revenue (JPY)
26 Q2	1.19T
26 Q1	1.22T
25 Q4	1.11T
25 Q3	1.21T
25 Q2	1.11T
25 Q1	1.11T
24 Q4	1.05T
24 Q3	1.14T
24 Q2	1.18T
24 Q1	1.21T

Net Income (JPY) · Q

TAK Net Income (JPY) by quarter
Period	Net Income (JPY)
26 Q2	192.43B
26 Q1	113.2B
25 Q4	-24.77B
25 Q3	105.51B
25 Q2	-11.8B
25 Q1	124.24B
24 Q4	-103.2B
24 Q3	23.79B
24 Q2	92.05B
24 Q1	95.25B

Operating Income (JPY) · Q

TAK Operating Income (JPY) by quarter
Period	Operating Income (JPY)
26 Q2	205.32B
26 Q1	201.42B
25 Q4	47.54B
25 Q3	194.06B
25 Q2	69B
25 Q1	184.57B
24 Q4	-74.9B
24 Q3	66.94B
24 Q2	184.25B
24 Q1	166.33B

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (JPY) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 28 Jan 2027.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Takeda Pharmaceutical Company Limited

Earnings: TAK

Video analysis: TAK

News: TAK

Similar companies